EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA binding proteins in cancer chemotherapeutic drug resistance

Hemanathan Vembuli, Ravi Gor, Satish Ramalingam, Selene Perales, Johnson Rajasingh

Frontiers in Cell and Developmental Biology · 24.01.2024 · 12

DOI: 10.3389/fcell.2024.1308102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 24.01.2024. Verfasst von Hemanathan Vembuli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Engineering, School of Bio-Engineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance has been a major obstacle in the quest for a cancer cure. Many chemotherapeutic treatments fail to overcome chemoresistance, resulting in tumor remission. The exact process that leads to drug resistance in many cancers has not been fully explored or understood. However, the discovery of RNA binding proteins (RBPs) has provided insight into various pathways and post-transcriptional gene modifications involved in drug tolerance. RBPs are evolutionarily conserved proteins, and their abnormal gene expression has been associated with cancer progression. Additionally, RBPs are aberrantly expressed in numerous neoplasms. RBPs have also been implicated in maintaining cancer stemness, epithelial-to-mesenchymal transition, and other processes. In this review, we aim to provide an overview of RBP-mediated mechanisms of drug resistance and their implications in cancer malignancy. We discuss in detail the role of major RBPs and their correlation with noncoding RNAs (ncRNAs) that are associated with the inhibition of chemosensitivity. Understanding and exploring the pathways of RBP-mediated chemoresistance will contribute to the development of improved cancer diagnosis and treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

RNA binding proteinsand lncRNAcancercancer stem cellsdrug resistancemiRNA

Autor:innen und Institutionen

  • Department of Genetic Engineering, School of Bio-Engineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
  • Department of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN, United States.
  • Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, United States.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Vembuli, H., Gor, R., Ramalingam, S., Perales, S., & Rajasingh, J. (2024). RNA binding proteins in cancer chemotherapeutic drug resistance. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1308102

Vancouver

Vembuli H, Gor R, Ramalingam S, Perales S, Rajasingh J. RNA binding proteins in cancer chemotherapeutic drug resistance. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1308102

BibTeX
@article{Vembuli2024,
  author = {Vembuli, Hemanathan and Gor, Ravi and Ramalingam, Satish and Perales, Selene and Rajasingh, Johnson},
  title = {RNA binding proteins in cancer chemotherapeutic drug resistance},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1308102}
}
Kostenlos starten →